HLB Therapeutics Co.,Ltd. HLB Therapeutics Co.,Ltd.

HLB Therapeutics Co.,Ltd.

115450

Clasificación en acciones #18716
HLB Therapeutics Co.,Ltd. operates as a biotechnology company, focusing on the... HLB Therapeutics Co.,Ltd. operates as a biotechnology company, focusing on the creation of pharmaceutical products for both the South Korean and international markets. A significant part of its research and development initiatives includes GBT-201, a compound utilizing Thymosin beta designed to treat various eye ailments such as dry eye syndrome and neurotrophic keratopathy. Additionally, the company is advancing OKN-007 as a potential therapy for glioblastoma brain tumors. Beyond its pharmaceutical endeavors, HLB Therapeutics is also involved in the wholesale distribution of vaccines and the production of electrical and electronic components like motors, pumps, and transformers. The company, which established its roots in 2000 and is based in Seongnam, South Korea, underwent a name change in December 2021, transitioning from its former identity as G-treeBNT Co., Ltd. to its current designation.
Precio por acción
$1.87
Capitalización bursátil
$176.28M
Cambio (1 día)
-0.55%
Cambio (1 año)
-10.80%
País
KR
Comercio HLB Therapeutics Co.,Ltd. (115450)

Categoría

Healthcare
Precio 115450 con Capital del mercado a B
HLB Therapeutics Co.,Ltd. HLB Therapeutics Co.,Ltd.
115450
$1.87
Capitalización de mercado de HLB Therapeutics Co.,Ltd.(115450)
Capitalización bursátil: $176.28M
A fecha de October 2026, HLB Therapeutics Co.,Ltd. tiene una capitalización de mercado de $176.28M. Esto convierte a HLB Therapeutics Co.,Ltd. en la 18716th empresa más valiosa del mundo por capitalización bursátil, según nuestros datos. La capitalización bursátil es el valor total de mercado de las acciones en circulación de una empresa que cotiza en bolsa y se utiliza comúnmente para medir su valor.
Historial de capitalización de mercado de HLB Therapeutics Co.,Ltd. desde 2010 hasta 2026
115450 en comparación con los más populares 5 títulos stocks
Precio por 115450 Activo B Capital del mercado en B Resultados
HLB Therapeutics Co.,Ltd. HLB Therapeutics Co.,Ltd.
$55,350.20 $176.28M
$5.216T +2,959,028.38%
HLB Therapeutics Co.,Ltd. HLB Therapeutics Co.,Ltd.
$52,543.40 $176.28M
$4.952T +2,808,971.32%
HLB Therapeutics Co.,Ltd. HLB Therapeutics Co.,Ltd.
$43,481.18 $176.28M
$4.098T +2,324,487.73%
HLB Therapeutics Co.,Ltd. HLB Therapeutics Co.,Ltd.
$41,821.20 $176.28M
$3.941T +2,235,741.82%
HLB Therapeutics Co.,Ltd. HLB Therapeutics Co.,Ltd.
$30,017.71 $176.28M
$2.829T +1,604,704.52%